Discovery of a potent thienodiazepine derivative as a novel BRD4 degrader
Bioorganic & Medicinal Chemistry · 2026
DOI: 10.1016/j.bmc.2026.118583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026. Verfasst von Mayu Shigekuni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Electronic address: mayu.shigekuni@tanabe-pharm…. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Transcription Factors, Antineoplastic Agents, Drug Discovery. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
We discovered bromodomain-containing protein 4 (BRD4) degraders as novel antitumor therapeutics leveraging our internal knowledge on Y-803 (birabresib, OTX015/MK-8628), which was discovered by our company as the first-in-class BRD4 inhibitor. Since we had obtained rich structure-activity relationship (SAR) information on its core skeleton, thienodiazepine, we designed and optimized Von Hippel-Lindau (VHL)-based BRD4 degraders based on the thienodiazepine scaffold. Here, we report that we obtained a novel, best-in-class BRD4 degrader, which showed a potent antitumor effect in a xenograft model of acute myeloid leukemia (AML).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Electronic address: mayu.shigekuni@tanabe-pharma.com.
- Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Electronic address: yasuki.niwa@tanabe-pharma.com.
- Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan.
- Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Electronic address: minoru.tanaka@tanabe-pharma.com.
Zitieren
APA
Shigekuni, M., Niwa, Y., Ohba, K., Hamada, M., Maruyama, H., Miyazaki, S., Iijima, D., Ooike, S., Fujita, R., Fukano, Y., Takahashi, T., Torimoto, N., Sakairi, T., Noguchi, K., Inoue, Y., & Tanaka, M. (2026). Discovery of a potent thienodiazepine derivative as a novel BRD4 degrader. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2026.118583
Vancouver
Shigekuni M, Niwa Y, Ohba K, Hamada M, Maruyama H, Miyazaki S, et al. Discovery of a potent thienodiazepine derivative as a novel BRD4 degrader. Bioorganic & Medicinal Chemistry. 2026. doi:10.1016/j.bmc.2026.118583
BibTeX
@article{Shigekuni2026,
author = {Shigekuni, Mayu and Niwa, Yasuki and Ohba, Kiyomi and Hamada, Maiko and Maruyama, Hideto and Miyazaki, Shiki and Iijima, Daisuke and Ooike, Shinsuke and Fujita, Ryo and Fukano, Yasufumi and Takahashi, Tsuyoshi and Torimoto, Nao and Sakairi, Tetsuya and Noguchi, Koji and Inoue, Yuki and Tanaka, Minoru},
title = {Discovery of a potent thienodiazepine derivative as a novel BRD4 degrader},
journal = {Bioorganic & Medicinal Chemistry},
year = {2026},
doi = {10.1016/j.bmc.2026.118583}
}
EUVIMED